Insider · CIK 0001827847
Robert W Postma
Files at TCRT (Alaunos Therapeutics, Inc.). First filing -, latest -.
Robert W Postma files SEC Form 4 as director at TCRT (Alaunos Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert W Postma has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | TCRT Alaunos Therapeutics, Inc. | AGrant or award Common Stock | +21,829 | $0.74 | $16k | 80,438 | 5 d ago |
| Apr 29, 2026 | TCRT Alaunos Therapeutics, Inc. | AGrant or award Common Stock | +6,274 | $2.59 | $16k | 50,146 | May 1, 2026 |
| Jan 12, 2026 | TCRT Alaunos Therapeutics, Inc. | AGrant or award Common Stock | +5,622 | $2.89 | $16k | 43,872 | Jan 15, 2026 |
| Nov 21, 2025 | TCRT Alaunos Therapeutics, Inc. | AGrant or award Common Stock | +5,142 | $3.16 | $16k | 38,250 | Nov 26, 2025 |
| Jul 3, 2025 | TCRT Alaunos Therapeutics, Inc. | AGrant or award Common Stock | +4,050 | $0.00 | $0 | 33,133 | Jul 7, 2025 |
| Jul 3, 2025 | TCRT Alaunos Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +6,400 | $0.00 | $0 | 6,400 | Jul 7, 2025 |
| Apr 13, 2025 | TCRT Alaunos Therapeutics, Inc. | AGrant or award Common Stock | +20,804 | $2.92 | $61k | 29,083 | Jun 26, 2025 |
| Apr 11, 2025 | TCRT Alaunos Therapeutics, Inc. | POpen-market purchase Series A-1 Convertible Preferred Stockderivativeindirect: By WaterMill Asset Management Corp. | +500 | $2.76 | $1,380 | 500 | Jun 26, 2025 |
| Jun 24, 2025 | TCRT Alaunos Therapeutics, Inc. | POpen-market purchase Series A-2 Convertible Preferred Stockderivativeindirect: By Watermill Asset Management Corp | +600 | $4.49 | $2,694 | 600 | Jun 26, 2025 |
| Apr 13, 2025 | TCRT Alaunos Therapeutics, Inc. | AGrant or award Common Stock | +20,804 | $2.92 | $61k | 29,083 | Apr 15, 2025 |
| Apr 11, 2025 | TCRT Alaunos Therapeutics, Inc. | POpen-market purchase Series A-1 Convertible Preferred Stockderivativeindirect: By WaterMill Asset Management Corp. | +500 | $2.76 | $1,380 | 500 | Apr 15, 2025 |
Questions about Robert W Postma
Answered from the filings on this page, as of the latest one.
Is Robert W Postma buying or selling?
Robert W Postma has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert W Postma's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert W Postma has 0.
Where does Robert W Postma file Form 4?
Robert W Postma has filed Form 4 at TCRT (Alaunos Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.